Menu
Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy » Volume 2
Precursors to invasive pancreatic cancer
Authors Smith, Singhi AD, Maitra A
Received 2 May 2012
Accepted for publication 25 July 2012
Published 27 August 2012 Volume 2012:2 Pages 19—27
DOI https://doi.org/10.2147/GICTT.S21839
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Jessica A Smith, Aatur D Singhi, Anirban Maitra
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, with a 5-year survival rate of less than 5%. To better understand PDAC and to improve its dismal prognosis, we must understand its origins. PDAC has three distinct noninvasive precursor lesions including intraductal papillary mucinous neoplasm, mucinous cystic neoplasm, and pancreatic intraepithelial neoplasia. Each of these precursor lesions has its own unique compendium of clinical findings, morphological features, and genetic aberrations. This review focuses on the clinical significance of precursor lesions of pancreatic cancer and how better understanding of these lesions can aid in early detection and treatment.
Keywords: pancreatic ductal adenocarcinoma, precursor lesions, intraductal papillary mucinous neoplasm, mucinous cystic neoplasm, pancreatic intraepithelial neoplasia, PanIN
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.